Artemisinin Combination Therapy Market Size, Share & Trends Report

Artemisinin Combination Therapy Market Size, Share & Trends Analysis Report By Type (Artemether+Lumefantrine, Artesunate+Amodiaquine), By Region, And Segment Forecasts, 2018 - 2025

  • Report ID: GVR-2-68038-592-2
  • Number of Pages: 90
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2016
  • Industry: Healthcare

Market Segmentation

  • Artemisinin Combination Therapy Type Outlook (Revenue, USD Million, 2014 - 2025)
    • Artemether-Lumefantrine
    • Artesunate-Amodiaquine
    • Dihydroartemisinin-Piperaquine
    • Artesunate-Mefloquine
    • Artesunate-Sulfadoxine-Pyrimethamine
    • Pyronaridine-Artesunate
  • Artemisinin Combination Therapy Region Outlook (Revenue, USD Million, 2014 - 2025)
    • Asia Pacific
      • China
        • China Artemisinin Combination Therapy Market, by Type
          • Artemether-Lumefantrine
          • Artesunate-Amodiaquine
          • Dihydroartemisinin-Piperaquine
          • Artesunate-Mefloquine
          • Artesunate-Sulfadoxine-Pyrimethamine
          • Pyronaridine-Artesunate
      • India
        • India Artemisinin Combination Therapy Market, by Type
          • Artemether-Lumefantrine
          • Artesunate-Amodiaquine
          • Dihydroartemisinin-Piperaquine
          • Artesunate-Mefloquine
          • Artesunate-Sulfadoxine-Pyrimethamine
          • Pyronaridine-Artesunate
      • Pakistan
        • Pakistan Artemisinin Combination Therapy Market, by Type
          • Artemether-Lumefantrine
          • Artesunate-Amodiaquine
          • Dihydroartemisinin-Piperaquine
          • Artesunate-Mefloquine
          • Artesunate-Sulfadoxine-Pyrimethamine
          • Pyronaridine-Artesunate
      • Indonesia
        • Indonesia Artemisinin Combination Therapy Market, by Type
          • Artemether-Lumefantrine
          • Artesunate-Amodiaquine
          • Dihydroartemisinin-Piperaquine
          • Artesunate-Mefloquine
          • Artesunate-Sulfadoxine-Pyrimethamine
          • Pyronaridine-Artesunate
      • Vietnam
        • Vietnam Artemisinin Combination Therapy Market, by Type
          • Artemether-Lumefantrine
          • Artesunate-Amodiaquine
          • Dihydroartemisinin-Piperaquine
          • Artesunate-Mefloquine
          • Artesunate-Sulfadoxine-Pyrimethamine
          • Pyronaridine-Artesunate
    • Latin America
      • Brazil
        • Brazil Artemisinin Combination Therapy Market, by Type
          • Artemether-Lumefantrine
          • Artesunate-Amodiaquine
          • Dihydroartemisinin-Piperaquine
          • Artesunate-Mefloquine
          • Artesunate-Sulfadoxine-Pyrimethamine
          • Pyronaridine-Artesunate
      • Colombia
        • Colombia Artemisinin Combination Therapy Market, by Type
          • Artemether-Lumefantrine
          • Artesunate-Amodiaquine
          • Dihydroartemisinin-Piperaquine
          • Artesunate-Mefloquine
          • Artesunate-Sulfadoxine-Pyrimethamine
          • Pyronaridine-Artesunate
    • Middle East & Africa
      • Nigeria
        • Nigeria Artemisinin Combination Therapy Market, by Type
          • Artemether-Lumefantrine
          • Artesunate-Amodiaquine
          • Dihydroartemisinin-Piperaquine
          • Artesunate-Mefloquine
          • Artesunate-Sulfadoxine-Pyrimethamine
          • Pyronaridine-Artesunate
      • Democratic Republic of Congo
        • Democratic Republic of Congo Artemisinin Combination Therapy Market, by Type
          • Artemether-Lumefantrine
          • Artesunate-Amodiaquine
          • Dihydroartemisinin-Piperaquine
          • Artesunate-Mefloquine
          • Artesunate-Sulfadoxine-Pyrimethamine
          • Pyronaridine-Artesunate
      • Mali
        • Mali Artemisinin Combination Therapy Market, by Type
          • Artemether-Lumefantrine
          • Artesunate-Amodiaquine
          • Dihydroartemisinin-Piperaquine
          • Artesunate-Mefloquine
          • Artesunate-Sulfadoxine-Pyrimethamine
          • Pyronaridine-Artesunate
      • Uganda
        • Uganda Artemisinin Combination Therapy Market, by Type
          • Artemether-Lumefantrine
          • Artesunate-Amodiaquine
          • Dihydroartemisinin-Piperaquine
          • Artesunate-Mefloquine
          • Artesunate-Sulfadoxine-Pyrimethamine
          • Pyronaridine-Artesunate
      • Kenya
        • Kenya Artemisinin Combination Therapy Market, by Type
          • Artemether-Lumefantrine
          • Artesunate-Amodiaquine
          • Dihydroartemisinin-Piperaquine
          • Artesunate-Mefloquine
          • Artesunate-Sulfadoxine-Pyrimethamine
          • Pyronaridine-Artesunate

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2014 to 2025
  • Market estimates and forecast for product segments up to 2025
  • Regional market size and forecast for product segments up to 2025
  • Market estimates and forecast for application segments up to 2025
  • Regional market size and forecast for application segments up to 2025
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon